Armata Pharmaceuticals Statistics
Total Valuation
ARMP has a market cap or net worth of $304.57 million. The enterprise value is $583.90 million.
Important Dates
The next estimated earnings date is Friday, May 22, 2026, after market close.
| Earnings Date | May 22, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ARMP has 36.70 million shares outstanding. The number of shares has decreased by -38.64% in one year.
| Current Share Class | 36.70M |
| Shares Outstanding | 36.70M |
| Shares Change (YoY) | -38.64% |
| Shares Change (QoQ) | +0.35% |
| Owned by Insiders (%) | 0.77% |
| Owned by Institutions (%) | 3.41% |
| Float | 11.34M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 62.11 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 119.07 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.19
| Current Ratio | 1.19 |
| Quick Ratio | 1.02 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.88 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -23.90% |
| Return on Invested Capital (ROIC) | -26.38% |
| Return on Capital Employed (ROCE) | -45.96% |
| Weighted Average Cost of Capital (WACC) | 8.13% |
| Revenue Per Employee | $81,733 |
| Profits Per Employee | -$2.90M |
| Employee Count | 60 |
| Asset Turnover | 0.06 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +505.84% in the last 52 weeks. The beta is 1.32, so ARMP's price volatility has been higher than the market average.
| Beta (5Y) | 1.32 |
| 52-Week Price Change | +505.84% |
| 50-Day Moving Average | 10.58 |
| 200-Day Moving Average | 6.47 |
| Relative Strength Index (RSI) | 38.51 |
| Average Volume (20 Days) | 74,364 |
Short Selling Information
The latest short interest is 244,306, so 0.67% of the outstanding shares have been sold short.
| Short Interest | 244,306 |
| Short Previous Month | 310,810 |
| Short % of Shares Out | 0.67% |
| Short % of Float | 2.16% |
| Short Ratio (days to cover) | 5.84 |
Income Statement
In the last 12 months, ARMP had revenue of $4.90 million and -$173.80 million in losses. Loss per share was -$4.80.
| Revenue | 4.90M |
| Gross Profit | -10.81M |
| Operating Income | -31.22M |
| Pretax Income | -173.80M |
| Net Income | -173.80M |
| EBITDA | -29.69M |
| EBIT | -31.22M |
| Loss Per Share | -$4.80 |
Full Income StatementBalance Sheet
The company has $8.69 million in cash and $288.02 million in debt, with a net cash position of -$279.33 million or -$7.61 per share.
| Cash & Cash Equivalents | 8.69M |
| Total Debt | 288.02M |
| Net Cash | -279.33M |
| Net Cash Per Share | -$7.61 |
| Equity (Book Value) | -218.60M |
| Book Value Per Share | -6.00 |
| Working Capital | 1.72M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$25.76 million and capital expenditures -$542,000, giving a free cash flow of -$26.31 million.
| Operating Cash Flow | -25.76M |
| Capital Expenditures | -542,000 |
| Depreciation & Amortization | 1.53M |
| Net Borrowing | 25.00M |
| Free Cash Flow | -26.31M |
| FCF Per Share | -$0.72 |
Full Cash Flow StatementMargins
| Gross Margin | -220.49% |
| Operating Margin | -636.66% |
| Pretax Margin | -3,544.03% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ARMP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 38.64% |
| Shareholder Yield | 38.64% |
| Earnings Yield | -57.06% |
| FCF Yield | -8.64% |
Analyst Forecast
The average price target for ARMP is $15.00, which is 80.72% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $15.00 |
| Price Target Difference | 80.72% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 73.01% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ARMP has an Altman Z-Score of -10.17 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -10.17 |
| Piotroski F-Score | 4 |
